Medtronic CEO Geoff Martha tempered expectations of a massive shift in the space, saying the companys initial work indicates minimal impact to its business
we realized we really needed to invest in the discontinuation phase and boost up our weight maintenance programming." Promising results While individuals that take GLP-1 injectable drugs for weight loss can achieve impressive results,researchers have thrown cold water on the belief users can simply quit taking the drug and expect to keep the weight off
Trulicity Trulicity, another diabetes drug developed by Eli Lilly, is also named in lawsuits that highlight the risks of gastrointestinal injuries, abdominal pain, nausea, and drug-induced pancreatitis
Pancreatitis incidence in the Exenatide BID, Exenatide QW, and Exenatide QW suspension Development Programs: pooled analysis of 35 clinical trials
Over time, this can lead to fatigue, headaches, dizziness, or low energy that affects your daily routine
